—

Zmiana pozwolenia na dopuszczenie do obrotu (art. 12 rozporządzenia Rady (EWG) nr 2309/93): przyjęte Data podjęcia decyzji Nazwa produktu leczniczego Posiadacz pozwolenia na dopuszczenie do obrotu Numer kolejny we wspólnotowym rejestrze Data powiadomienia 16.11.2004 Tamiflu Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AY, United Kingdom EU/1/02/222/001 18.11.2004 17.11.2004 Trizivir Glaxo Group Ltd, Greenford, Middlesex, UB6 0NN, United Kingdom EU/1/00/156/001-003 19.11.2004 17.11.2004 Targretin Ligand Pharmaceuticals UK Ltd, Innovis House, 108 High Street, Crawley, West Sussex, RH10 1BB, United Kingdom EU/1/01/178/001 19.11.2004 25.11.2004 Bextra Pharmacia-Pfizer EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom EU/1/02/239/001-024 29.11.2004 25.11.2004 ReFacto Wyeth Europa Ltd, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom EU/1/99/103/001-004 29.11.2004 30.11.2004 Xigris Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland EU/1/02/225/001-002 2.12.2004 30.11.2004 Tracleer Actelion Registration Ltd, BSI Building, 13th Floor, 389 Chiswick High Road, London W4 4AL, United Kingdom EU/1/02/220/001-005 2.12.2004 30.11.2004 Cialis Lilly ICOS Limited, St Bride's House, 10 Salisbury Square, London, EC4Y 8EH, United Kingdom EU/1/02/237/001 EU/1/02/237/005 2.12.2004 1.12.2004 Micardis Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein EU/1/98/090/001-014 3.12.2004 6.12.2004 Integrilin Glaxo Group Ltd, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, United Kingdom Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Stallestraat 73, B-1180 Brussel EU/1/99/109/001-002 8.12.2004 6.12.2004 Epivir Glaxo Group Ltd, Greenford Road, Greenford, Middlesex, UB6 0NN, United Kingdom EU/1/96/015/001-005 8.12.2004 6.12.2004 Dynastat Pharmacia Europe EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom EU/1/02/209/001-008 8.12.2004 6.12.2004 Sustiva Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, Hounslow, TW3 3JA, United Kingdom EU/1/99/110/001-009 8.12.2004 6.12.2004 NutropinAq IPSEN Limited, 190 Bath Road, Slough, Berkshire, SLI 3XE, United Kingdom EU/1/00/164/001-005 8.12.2004 6.12.2004 Strocrin Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, United Kingdom EU/1/99/111/001-009 8.12.2004 6.12.2004 Dynastat Pharmacia Europe EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom EU/1/02/209/001-008 8.12.2004 6.12.2004 Panretin Ligand Pharmaceuticals UK Ltd, Innovis House, 108 High Street, Crawley, West Sussex, RH10 1BB, United Kingdom EU/1/00/149/001 8.12.2004 6.12.2004 Arava Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main EU/1/99/118/001-010 8.12.2004 6.12.2004 Viread Gilead Sciences International Limited, Cambridge, CB1 6GT United Kingdom EU/1/01/200/001 8.12.2004 6.12.2004 Rayzon Pharmacia Europe EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom EU/1/02/210/001-008 8.12.2004 6.12.2004 Rayzon 6m Pharmacia Europe EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom EU/1/02/210/001-008 8.12.2004 7.12.2004 Kinzalmono Bayer AG, D-51368 Leverkusen EU/1/98/091/001-014 9.12.2004 7.12.2004 Micardis Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein EU/1/98/090/001-014 10.12.2004 7.12.2004 Pritor Glaxo Group Ltd, Greenford, Middlesex, UB6 0NN, United Kingdom EU/1/98/089/001-016 9.12.2004